Mariolina Salio Selected Research

Mariolina Salio Research Topics

Disease

14	Neoplasms (Cancer) 03/2024 - 05/2002
9	Infections 12/2021 - 09/2004
4	Inflammation (Inflammations) 11/2019 - 09/2004
2	Virus Diseases (Viral Diseases) 12/2021 - 01/2020
2	COVID-19 11/2020 - 06/2020
2	Hypersensitivity (Allergy) 02/2016 - 01/2016
2	Skin Diseases (Skin Disease) 02/2016 - 02/2015
2	Bacterial Infections (Bacterial Infection) 01/2015 - 12/2013
2	Autoimmune Diseases (Autoimmune Disease) 03/2008 - 10/2007
2	Melanoma (Melanoma, Malignant) 02/2004 - 10/2002
1	Tuberculosis (Tuberculoses) 05/2024
1	Non-Muscle Invasive Bladder Neoplasms 05/2023
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2023
1	Iron Deficiencies 12/2021
1	Pneumonia (Pneumonitis) 12/2021
1	Starvation 11/2021
1	Atopic Dermatitis (Atopic Eczema) 02/2016
1	Venom Hypersensitivity 01/2016
1	Fabry Disease (Fabry's Disease) 09/2012
1	Carcinoma (Carcinomatosis) 03/2007
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 10/2006
1	Vaccinia 11/2003
1	Communicable Diseases (Infectious Diseases) 05/2002
1	Colorectal Neoplasms (Colorectal Cancer) 01/2002

Drug/Important Bio-Agent (IBA)

8	Peptides (Polypeptides)IBA 05/2024 - 05/2002
7	AntigensIBA 01/2023 - 10/2002
6	LipidsIBA 01/2023 - 10/2006
4	LigandsIBA 01/2021 - 12/2004
4	Proteins (Proteins, Gene)FDA Link 06/2020 - 05/2002
3	VaccinesIBA 12/2021 - 12/2004
3	CytokinesIBA 01/2020 - 11/2010
2	Arginine (L-Arginine)FDA Link 03/2024 - 11/2021
2	ArginaseIBA 11/2021 - 12/2008
2	InterferonsIBA 01/2021 - 11/2020
2	Phospholipases (Phospholipase)IBA 01/2016 - 02/2015
2	GlycosphingolipidsIBA 12/2013 - 10/2006
2	GlycolipidsIBA 03/2008 - 10/2007
1	RNA (Ribonucleic Acid)IBA 03/2024
1	pembrolizumabIBA 05/2023
1	Lipoproteins (Lipoprotein)IBA 01/2023
1	MicronutrientsIBA 12/2021
1	IronIBA 12/2021
1	Neutralizing AntibodiesIBA 12/2021
1	HepcidinsIBA 12/2021
1	ChromatinIBA 11/2021
1	Argininosuccinate Synthase (Argininosuccinate Synthetase)IBA 11/2021
1	Histones (Histone)IBA 11/2021
1	CitrullineIBA 11/2021
1	ElementsIBA 01/2021
1	Immunodominant EpitopesIBA 06/2020
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 06/2020
1	Cancer VaccinesIBA 01/2017
1	HaptensIBA 02/2016
1	Filaggrin ProteinsIBA 02/2016
1	VenomsIBA 01/2016
1	Wasp Venoms (Venom, Wasp)IBA 01/2016
1	Galactosylceramides (Galactocerebrosides)IBA 05/2015
1	SaposinsIBA 12/2013
1	isoglobotrihexosylceramideIBA 09/2012
1	GalactosidasesIBA 09/2012
1	GlobosidesIBA 09/2012
1	Toll-Like Receptor AgonistsIBA 12/2008
1	AntibodiesIBA 06/2008
1	alpha-galactosylceramideIBA 03/2008
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 03/2007
1	Ribavirin (Virazole)FDA LinkGeneric 09/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2004
1	Interferon-alpha (Interferon Alfa)IBA 09/2004
1	CEACAM1 ProteinIBA 03/2004
1	HLA-A2 Antigen (HLA A2 Antigen)IBA 02/2004
1	DNA (Deoxyribonucleic Acid)IBA 11/2003
1	EpitopesIBA 10/2002
1	Combined VaccinesIBA 10/2002
1	Synthetic Vaccines (Recombinant Vaccines)IBA 05/2002

Therapy/Procedure

4	Immunotherapy 01/2021 - 01/2002
2	Therapeutics 06/2020 - 05/2015
1	Drug Therapy (Chemotherapy) 01/2021
1	Radiotherapy 01/2021